Sensorium Therapeutics
PrivateLast Round
Series A
Extension
Aug 20, 2025
Total Funding Raised
$55M
Company Overview
Sensorium Therapeutics is a biotechnology company that develops nature-derived psychoactive medicines for mental and brain health conditions using its proprietary AI-driven discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensorium Therapeutics Comparables
Compare Sensorium Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mindstate Design Labs | 87% | |
| Otsuka Holdings | 84% | |
| Delix Therapeutics | 83% | |
Sensorium Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 20, 2025 | ||||
| Series A | Nov 8, 2022 |
Key People
Founding team and executive leadership
Sensorium Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A Extension |
| H. Barton Asset Management | Series A Extension |
| Hatteras Venture Partners | Series A Extension |
| re.Mind Capital | Series A |
| Iter Investments | Series A |
| Mockingbird Capital Partners | Series A Extension |
| Palo Santo | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2025
Jacob Hooker, PhD, appointed as new Chief Executive Officer.
- Jul 9, 2025
Simba Gill appointed Executive Chairman of the Board of Directors.
Sensorium Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sensorium Therapeutics's valuation, stock price, and market status.